NormOxys Obtains $1,556,353 New Round

  • Feed Type
  • Date
    6/24/2011
  • Company Name
    NormOxys
  • Mailing Address
    16 Laurel Ave. Wellesley, MA 02481
  • Company Description
    NormOxys is developing a novel class of small molecule drugs, oxyrens, which enhance the body’s ability to deliver oxygen more efficiently to diseased tissues with oxygen deficiency. This new class of drugs can be potentially developed in a broad range of clinical indications where therapeutic benefit can be obtained through an increased, regulated delivery of oxygen to hypoxic tissues, such as cancer, cardiovascular diseases, anemia, stroke and diabetic retinopathy.
  • Website
    http://www.normoxys.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,556,353
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Convertible promissory notes. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy